BamSEC and AlphaSense Join Forces
Learn More
You must log in to view this page.

Relmada Therapeutics Inc. – Ownership Summary

NASDAQ: RLMD    
Share price (10/2/26): $3.60    
Market cap (10/2/26): $384 million